Suppliers / Zhejiang Yongtai Chiral Medicine Technology

Zhejiang Yongtai Chiral Medicine Technology

China Updated 9 July 2026

Zhejiang Yongtai Chiral Medicine Technology is an API manufacturer based in China. It holds 7 active US drug master files and 5 valid CEPs across a filed portfolio of 5 molecules.

7
active US DMFs
5
valid CEPs
3
registered plants 1 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026.

Registered plants

Site FDA FEI
Taizhou, China Not on file
China, China 3019367584
Taizhou City, China Not on file

What they file, and where

Molecule Regulators Docs
Carbidopa EDQM, US FDA 3
Sitagliptin US FDA 3
Gabapentin EDQM, US FDA 2
Levodopa EDQM, US FDA 2
Methyldopa EDQM, US FDA 2

Also appears on these molecule pages

Carbidopa API Gabapentin API Levodopa API Sitagliptin API

Comparing suppliers?

Choose your molecules and target markets. Zhejiang Yongtai Chiral Medicine Technology comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability